Sign in to our online system or register for a new account to submit a letter of intent.
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.
The Rapid Response: Canada program was created to provide seed funding to catalyse novel, high-risk, high-reward translational research. Preliminary data is not required.
Note: The program dates for the Parkinson’s & Related Diseases stream have been extended. The deadline for LOIs is now May 15, 2019. Please refer to the important dates section below.
Goal: To provide seed funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.
Funding: A maximum of $300,000 over up to 18 months per project.
Applicant Eligibility: Eligible Principal Applicants must be working in Canada at least 30% of the time at or above the level of Postdoctoral researcher, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. Co-Applicants/Collaborators must be at the post-doctoral level or above and can be working outside Canada.
If the Principal Applicant is not appointed at the institution from which they are applying, they need to apply with a research supervisor (an “Administrative Supervisor”) who is at or above the level of Assistant Professor or equivalent, with an appointment at the institution from which they are applying.
Applicants may appear in any role on any number of projects.
Project Eligibility: Projects must meet two conditions to be eligible:
*Preliminary data is not required for this program
Please refer to What We Fund for Institute definitions of neurodegenerative diseases of aging, translational research, therapeutic/tool, and complementary approaches.
The Rapid Response program will have multiple calls per year, alternating between two different disease groups (outlined below). Applicants should apply to the group best suited to their project.
|Alzheimer’s & Related Diseases:||Parkinson’s & Related Diseases:|
|o Alzheimer’s disease||o Parkinson’s disease|
|o Frontotemporal dementia||o Dementia with Lewy bodies|
|o Mild cognitive impairment||o Multiple system atrophy|
|o Vascular contributions to the above||o Progressive supranuclear palsy|
|o Prodromes to the above||o Vascular contributions to the above|
|o Prodromes to the above|
The Institute welcomes additional inquiries about this program, including whether a potential idea is in scope. For questions related to the Parkinson’s & Related Diseases program, please contact Matthew Sacheli. For questions related to the Alzheimer’s & Related Diseases program, please contact Rene Prashad.
There are two stages of the application process:
An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be sent to those invited.
Parkinson’s & Related Diseases (PD, PSP, DLB, MSA, prodromes, and vascular contributions to the listed diseases)
Alzheimer’s & Related Diseases (AD, FTD, MCI, and vascular contributions and prodromes to the listed diseases)
|Parkinson’s & Related Diseases: Note: The program dates have been extended. The deadline for LOIs is now May 15, 2019.|
|Program opens:||Currently Open|
|LOI deadline:||May 15, 2019 at 2:00pm EDT|
|Proposal deadline:||September 25, 2019 at 2:00pm EDT|
|Anticipated award notification:||December 2019|
|Alzheimer’s & Related Diseases:|
|Program opens:||Program is now closed|
|Proposal deadline:||July 30, 2019 at 2:00pm EDT|
|Anticipated award notification:||October 2019|
The Institute will hold a Program Information Webinar for each disease focus, to provide further details on the program and answer any questions. However, if you have questions specific to your project (e.g., project scope), we encourage you to contact us.
Parkinson’s & Related Diseases: April 3, 2019 at 1:00pm EDT
Webinar has now passed.
Alzheimer’s & Related Diseases: February 27, 2019 at 1:00pm EST
Webinar has now passed.
Funding (up to $1.5m) to grantees outside the regular granting mechanism in order to avoid delays in supporting exciting, potentially high-reward work based on previous success for grants awarded by the Weston Brain Institute.
If you’re a current or past Institute grantee, and would like to apply for follow-on funding, please visit the Weston Brain Institute Follow-on Funding page for more details on how to apply.